US: AIHLF - Adcock Ingram Holdings Limited

Rentabilidad a seis meses: 0%

Calendario de promoción Adcock Ingram Holdings Limited


Acerca de la empresa

Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services.

más detalles
The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products and services. It offers its products for allergies, antiretroviral, baby care, cardiovascular, cannabidiol, central nervous system, colds and flu, cough, dermatology, digestive well-being, energy, feminine hygiene, food and nutrition supplements, gastroenterology, generics, ophthalmology, pain, personal care, respiratory, vitamins, minerals supplements, and women's health. The company also provides critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.

EBITDA 17.94
EV/EBITDA 0.6991
Industry Pharmaceuticals
P/BV 0.161
P/E 1.08
P/S 0.0994
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 127.25
Див.доход ао 172.18
Дивиденд ао 1.59
Сайт https://www.adcock.co.za
Цена ао 2.45
Число акций ао 0.15463 млрд
Cambio de precio por día: 0% (2.45)
Cambio de precio por semana.: 0% (2.45)
Cambio de precio por mes: 0% (2.45)
Cambio de precio en 3 meses.: 0% (2.45)
Cambio de precio en seis meses: 0% (2.45)
Cambio de precio por año: 0% (2.45)
Cambio de precio en 3 años.: -21.97% (3.14)
Cambio de precio en 5 años.: -43.16% (4.31)
Cambio de precio en 10 años.: 0% (2.45)
Cambio de precio desde principios de año.: 0% (2.45)

Subestimación

Nombre Significado Calificación
P/S 0.7119 10
P/BV 0.0703 10
P/E 8.43 9
EV/EBITDA 7.25 9
Total: 8.63

Eficiencia

Nombre Significado Calificación
ROA, % 1.02 1
ROE, % 1.58 1
Total: 1.67

Dividendos

Nombre Significado Calificación
Div yield, % 166.72 10
DSI 0.8571 8.57
Total: 8.51

Deber

Nombre Significado Calificación
Debt/EBITDA 3.55 3
Total: 5.8

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % -92.9 0
Rentabilidad Ebitda, % -92.56 0
Rentabilidad EPS, % 20.99 4
Total: 0.8

Supervisor Título profesional Pago año de nacimiento
Mr. Andrew Gideon Hall CA (SA), BPharm CEO & Executive Director 1962 (63 año)
Ms. Dorette Neethling CFO & Executive Director 1974 (51 año)
Ms. Basadifeela Letsoalo Executive Director of Transformation & Human Capital and Executive Director 1963 (62 año)
R. Essa Corporate Finance Director
Mr. Mahlatse Phalafala Company Secretary & Head of Legal
Mr. Nkosinathi Mthethwa Public Affairs Executive
Mr. Ashley Pearce Dip. Pharm, BCom Managing Director of Prescription
Mr. Colin Sheen B.Tech., M.B.A., NDip Mktg, PDBA Managing Director of Hospital
Mr. Tobie Krige MBA Managing Director of Distribution
Mr. Azhar Kaka Head of Sales - Consumer Division

DIRECCIÓN: South Africa, Midrand, 1 New Road - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.adcock.co.za